allogeneic adipose tissue-derived multi-lineage progenitor cell therapy (Adipo Medical Technology/Otsuka)

N/A

Report date: 2025/03/14 16:20:40

Base Information

Drug Nameallogeneic adipose tissue-derived multi-lineage progenitor cell therapy (Adipo Medical Technology/Otsuka)
Drug Alias Nameallogeneic adipose mesenchymal stem cell-derived cell therapy (Adipo Medical Technology/Otsuka)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdipo Medical Technology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdipo Medical Technology IncOtsuka Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A